<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Codexis, Inc. News Release</title><link>http://ir.codexis.com/phoenix.zhtml?c=208899&amp;p=irol-news</link><description>A Collection of Codexis, Inc. News Release</description><language>en-us</language><category>Uncategorized</category><lastBuildDate>Wed, 22 May 2013 05:42:39 GMT</lastBuildDate><item><title>Codexis to Present at 2013 UBS Global Healthcare Conference</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1819691</link><description><![CDATA[REDWOOD CITY, Calif.--(BUSINESS WIRE)--May. 14, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
      pharmaceutical, biofuel and chemical production, today announced that
      John Nicols, President and CEO of Codexis, will present a company
      overview at the 2013 UBS Global Healthcare Conference on Monday, May 20,
      2013 at 3:00 p.m. ET in New York City.
    

      A live webcast and replay will be available on the Investors section of
      the company's website, http://ir.codexis.com/.
    

      About Codexis, Inc.
    

      Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical
      production. Codexis’ pr...]]></description><category>Uncategorized</category><guid isPermaLink="false">1819691_NEWS</guid><pubDate>Tue, 14 May 2013 20:20:52 GMT</pubDate></item><item><title>Codexis Reports First Quarter 2013 Results</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1816589</link><description><![CDATA[-- Product gross margin increases to 38%; Product revenue up 34% from
      fourth quarter 2012 --
    

      -- Conference call today at 4:30 pm ET --
    
    REDWOOD CITY, Calif.--(BUSINESS WIRE)--May. 7, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
      pharmaceutical, biofuel and chemical production, today announced
      financial results for the first quarter ended March 31, 2013.
    

      “We are very encouraged by the continued growth of our pharmaceutical
      business during the first quarter, which demonstrated strong sales and
      profit expansion,” said John Nicols, President and CEO of Codexis.
      “These improvement...]]></description><category>Uncategorized</category><guid isPermaLink="false">1816589_NEWS</guid><pubDate>Tue, 07 May 2013 20:01:49 GMT</pubDate></item><item><title>Codexis to Announce First Quarter 2013 Financial Results on May 7, 2013</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1812212</link><description><![CDATA[REDWOOD CITY, Calif.--(BUSINESS WIRE)--Apr. 29, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
      pharmaceutical, biofuel and chemical production, today announced it will
      host a live conference call and audio webcast on Tuesday, May 7, 2013 at
      4:30 p.m. Eastern Time to discuss its first quarter 2013 financial
      results for the period ended March 31, 2013. The call and webcast will
      follow the release of first quarter financial results after market
      close. A recorded version of the call will be available approximately
      one hour after the call on the Investors section of the company's
      website, www.codexis.com,
...]]></description><category>Uncategorized</category><guid isPermaLink="false">1812212_NEWS</guid><pubDate>Mon, 29 Apr 2013 12:30:52 GMT</pubDate></item><item><title>Codexis to Present at 2013 BIO International Convention</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1809331</link><description><![CDATA[REDWOOD CITY, Calif.--(BUSINESS WIRE)--Apr. 22, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
      pharmaceutical, biofuel and chemical production, announced today that
      Gjalt Huisman, Ph.D., Vice President, Pharmaceutical R&amp;D at Codexis,
      will present at the 2013 BIO International Convention in Chicago, IL, on
      Tuesday, April 23, 2013. Dr. Huisman will present an overview of the
      company's application of its CodeEvolver® directed evolution
      technology platform in the field of enzyme therapeutics.
    

      “Codexis’ technology has revolutionized the manufacture of
      pharmaceuticals and is currently used in the...]]></description><category>Uncategorized</category><guid isPermaLink="false">1809331_NEWS</guid><pubDate>Mon, 22 Apr 2013 20:15:13 GMT</pubDate></item><item><title>Codexis Announces Next Generation CodeXyme® Cellulase Enzymes with Leading Performance</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1794687</link><description><![CDATA[Compared to prior generations, CodeXyme® 4 and CodeXyme® 4X significantly reduce the cost of cellulosic sugar production for biofuels and bio-based chemicals 
REDWOOD CITY, Calif. -- (Revised Version May 1, 2013; Original Version March 12, 2013) -- Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced today the launch of CodeXyme® 4 and CodeXyme® 4X cellulase enzyme packages for use in producing cellulosic sugar for production of biofuels and bio-based chemicals. 
Codexis’ latest generation of advanced cellulase enzymes, CodeXyme® 4 for dilute acid pretreatments and CodeXyme® 4X for hydrothermal pretreatments, exhibit...]]></description><category>Uncategorized</category><guid isPermaLink="false">1794687_NEWS</guid><pubDate>Tue, 12 Mar 2013 09:00:00 GMT</pubDate></item><item><title>Codexis Reports Fourth Quarter and Full Year 2012 Results</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1790090</link><description><![CDATA[
      -- Conference call today at 4:30 pm ET --
    
    REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 27, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
      pharmaceutical, biofuel and chemical production, today announced
      financial results for the fourth quarter and year ended December 31,
      2012.
    

      “After a period of transition in 2012, we are very encouraged by the
      company’s progress and our better than projected cash balance at the end
      of the year,” said John Nicols, President and CEO of Codexis. “While
      making necessary strategic reductions of our operational expenses and
      cash burn associated wit...]]></description><category>Uncategorized</category><guid isPermaLink="false">1790090_NEWS</guid><pubDate>Wed, 27 Feb 2013 21:01:58 GMT</pubDate></item><item><title>Strem and Codexis Sign Enzyme Distribution Agreement</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1786204</link><description><![CDATA[    NEWBURYPORT, Mass. &amp; REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 19, 2013--
      Strem Chemicals, Inc., a manufacturer of specialty chemicals for
      research and development and Codexis, Inc. (NASDAQ: CDXS), a developer
      of world-leading enzymes and processes for the production of
      pharmaceuticals, biofuels and bio-based chemicals, today announced the
      signing of an enzyme distribution agreement.
    

      The agreement grants Strem exclusive distribution rights for the new
      100mg CODEX® Screening Kits for Codexis’ popular Transaminase
      and Ketoreductase enzyme platforms. These enzymes enable efficient
      conversion of ketones to chiral al...]]></description><category>Uncategorized</category><guid isPermaLink="false">1786204_NEWS</guid><pubDate>Tue, 19 Feb 2013 14:00:43 GMT</pubDate></item><item><title>Codexis to Participate in Informex USA 2013 Conference</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1785735</link><description><![CDATA[
      -Company to Highlight its Enzymatic Technology Breakthroughs and
      Market Opportunities in Fine Chemicals Sector-
    
    REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 15, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and
      processes for the production of pharmaceuticals, biofuels and bio-based
      chemicals, announced today that it will exhibit the Company’s enzymatic
      approaches for the fine chemicals industry at the Informex USA 2013
      Conference, being held at the Anaheim Convention Center in Anaheim,
      Calif., from February 19-22, 2013.
    

      The Company will use the opportunity to discuss its technology
...]]></description><category>Uncategorized</category><guid isPermaLink="false">1785735_NEWS</guid><pubDate>Fri, 15 Feb 2013 22:45:00 GMT</pubDate></item><item><title>Codexis to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on February 27, 2013</title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1785423</link><description><![CDATA[    REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 14, 2013--
      Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and
      processes for the production of pharmaceuticals, biofuels and bio-based
      chemicals, today announced it will host a live conference call and audio
      webcast on Wednesday, February 27, 2013 at 4:30 p.m. Eastern Time to
      discuss its fourth quarter and fiscal year 2012 financial results for
      the period ended December 31, 2012. The call and webcast will follow the
      release of fourth quarter and fiscal year financial results after market
      close. A recorded version of the call will be available approximately
      one hou...]]></description><category>Uncategorized</category><guid isPermaLink="false">1785423_NEWS</guid><pubDate>Thu, 14 Feb 2013 21:38:53 GMT</pubDate></item><item><title>AMRI and Codexis Announce Technology Collaboration </title><link>http://phx.corporate-ir.net/phoenix.zhtml?c=208899&amp;p=RssLanding&amp;cat=news&amp;id=1784807</link><description><![CDATA[SMARTSOURCING™ Partnership to Focus on Improved Process Development
Download PDF

Albany, NY and Redwood City, CA (February 13, 2013) — AMRI (NASDAQ: AMRI) and Codexis (NASDAQ: CDXS) announced today that they have entered into a SMARTSOURCING™ partnership. The collaboration will provide opportunities to combine the two companies’ capabilities and technologies for specific customer projects, yielding increased value to customers in the form of potentially lower costs, greater yields, cleaner processes and/or faster turnaround times.

Under this non-exclusive, two-year agreement, the companies will align their respective strengths to identify and implement new and improved manufacturing route...]]></description><category>Uncategorized</category><guid isPermaLink="false">1784807_NEWS</guid><pubDate>Wed, 13 Feb 2013 20:40:00 GMT</pubDate></item></channel></rss>